The Manufacturers Life Insurance Company Sells 165,563 Shares of Haleon plc (NYSE:HLN)

The Manufacturers Life Insurance Company trimmed its position in shares of Haleon plc (NYSE:HLN - Free Report) by 8.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,788,741 shares of the company's stock after selling 165,563 shares during the period. The Manufacturers Life Insurance Company's holdings in Haleon were worth $18,925,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Fortitude Family Office LLC bought a new stake in Haleon during the 3rd quarter valued at approximately $28,000. Cultivar Capital Inc. bought a new stake in shares of Haleon in the second quarter valued at approximately $40,000. Hexagon Capital Partners LLC grew its stake in shares of Haleon by 66.6% in the second quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company's stock worth $55,000 after acquiring an additional 2,677 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Haleon during the third quarter worth $57,000. Finally, BOKF NA raised its stake in Haleon by 68.8% during the 2nd quarter. BOKF NA now owns 6,972 shares of the company's stock valued at $58,000 after purchasing an additional 2,842 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Price Performance

NYSE HLN traded down $0.06 during trading on Friday, reaching $9.66. 2,989,952 shares of the company traded hands, compared to its average volume of 6,345,891. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80. The company has a market cap of $43.73 billion, a price-to-earnings ratio of 28.41, a P/E/G ratio of 2.92 and a beta of 0.30. The stock's 50 day moving average price is $9.92 and its two-hundred day moving average price is $9.43. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Analyst Ratings Changes

Several research analysts have recently issued reports on HLN shares. Berenberg Bank initiated coverage on shares of Haleon in a report on Tuesday, August 6th. They set a "buy" rating on the stock. UBS Group upgraded Haleon to a "strong-buy" rating in a research note on Tuesday, October 1st. The Goldman Sachs Group downgraded Haleon from a "buy" rating to a "neutral" rating in a research report on Tuesday, August 6th. Finally, Morgan Stanley lifted their price objective on Haleon from $9.90 to $10.95 and gave the stock an "overweight" rating in a report on Friday, September 20th. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.